Recurrent and persistent hematuria with diffuse membranous glomerulonephritis
ICD-10 N02.2 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with diffuse membranous glomerulonephritis.
N02.2 refers to a condition characterized by recurrent and persistent hematuria, which is the presence of blood in the urine, associated with diffuse membranous glomerulonephritis. This type of glomerulonephritis is an autoimmune disorder where the immune system mistakenly attacks the glomeruli, leading to inflammation and damage. Patients typically present with symptoms such as hematuria, proteinuria, and edema. The condition can lead to nephrotic syndrome, which is characterized by significant protein loss in urine, low serum albumin levels, and swelling due to fluid retention. Diagnosis often involves renal biopsy, which may reveal thickening of the glomerular capillary walls and subepithelial immune complex deposits. Management of this condition typically includes corticosteroids and immunosuppressive agents to reduce inflammation and prevent further kidney damage. Regular monitoring of renal function and urine analysis is essential to assess disease progression and response to treatment.
Detailed clinical notes on hematuria, proteinuria, and renal function tests.
Patients presenting with unexplained hematuria, proteinuria, or edema.
Ensure clear documentation of biopsy findings and treatment plans.
Comprehensive reports on renal biopsy findings.
Evaluation of renal tissue for glomerular diseases.
Accurate description of histological findings is crucial for coding.
Used when a renal biopsy is performed to confirm diagnosis.
Document indication for biopsy and findings.
Nephrologists must ensure biopsy results are clearly linked to the diagnosis.
Renal biopsy is crucial for confirming the diagnosis of diffuse membranous glomerulonephritis and helps guide treatment decisions.
